Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director, Gyo Sagara; “ONO”) today announced that the pending conditions of Stock Options (Stock Acquisition Rights) resolved at the meeting of Board of Directors held on June 17, 2021 have been determined.